John is originally from Bangor, Northern Ireland. He received his Ph.D. under the supervision of Professor Sir Alec J. Jeffreys from the University of Leicester, England. Prior to achieving his Ph.D. he studied genetics at the University of Edinburgh, Scotland. His Ph.D. thesis concerned the study of recombination mechanisms in human minisatellite DNA.

After receiving his Ph.D., John became a Post-Doctoral Fellow in New York under the supervision of Dr. Larry Shapiro at Mt. Sinai School of Medicine and later Columbia University. His post-doctoral work studied the structure of calcium-dependent cell adhesion molecules through the use of x-ray crystallography.

John's practice focuses on complex life sciences litigation, prosecution and opinion work. He has particular experience in Hatch-Waxman litigation, biotechnology and medical device prosecution and generic pharmaceuticals opinion work.

Publications:
A. Anthony Pfeffer and John Murray, Ph.D., "Challenges to Stem Cell Patents in Europe and the U.S." The Intellectual Property Strategist, December 2007.

Presentations: 

Significant Matters: Assisted in representation of a major generic pharmaceuticals firm in ANDA litigation regarding generic esomeprazole, which resulted in a favorable settlement for the generic supplier.